top of page

Knowledge

The need for objective adherence monitoring

5.png
6.png

01 Mar 2019

Taylor & Francis Group

Challenges to PrEP use

and perceptions of urine
tenofovir adherence monitoring

Maximizing the impact of HIV pre-exposure prophylaxis (PrEP) requires optimizing access and adherence for those at risk of contracting HIV.

2018

04-06 JUNE 2017

7.png

UrSure tests are accurate

8.png
9.png
10.png

2019

UrSure Assay for TFV to Monitor Adherence in real time to TDF/FTC as PrEP

Poster

Paper

31 Dec 2016

UrSure tests have clinical impact

11.png
12.png
13.png
14.png
15.png

01 Mar 2019

01 Oct 2018

Prevention Research

Delivery of TDF/FTC for PrEP to Prevent HIV Using a Urine Adherence Assay

Pre-exposure prophylaxis (PrEP) for HIV prevention with daily tenofovir and emtricitabine is effective when taken consistently. 

2018

2020

2020

2020

16.png
bottom of page